Trials Sponsors Conditions Drugs Pricing

Conditions

Liver Cancer Sarcopenia

Keywords

SarcopeniaLiver cancerHepatectomyShort-term outcomesLong-term outcomes

Outcome Measures

Primary Outcomes (2)

Short-term postoperative results
Postoperative complications；90 days readmission rate
3 months
Long-term results after operation
Overall survival; Disease free survival
10 years

Secondary Outcomes (2)

Postoperative hospitalization time
2 months
Hospitalization expenses
2 months

Interventions

gait speed; ct scan;grip strength and chair stand testDiagnostic test

The chair stand test was administered, and the time required for the patient to stand five times from a sitting position without using the arms was measured. CT scan was to scan the patient's third lumbar level. For the gait speed test, the time that patients spent walking 8 meters on a flat indoor floor at usual walking speed was measured.Grip strength test:the dominant hand and the nondominant hand were measured twice intermittently (kg), and the average value of 4 values was obtained.

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Patients with preoperative clinical diagnosis of liver cancer admitted to the hepatobiliary surgery department and received standard tests and questionnaires.

You may qualify if:

Patients with preoperative clinical diagnosis of liver cancer

Sponsors & Collaborators

First Affiliated Hospital of Wenzhou Medical University
Otherlead
The Second Hospital of Shandong University
Othercollaborator

Study Sites (1)

Gang Chen

Wenzhou, Zhejiang, 325000, China

Biospecimen

Retention: SAMPLES WITH DNA

night soil；whole blood；Tissue specimen

MeSH Terms

Conditions

Liver NeoplasmsSarcopenia

Interventions

Walking Speed

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesLiver DiseasesMuscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, Anatomical

Study Officials

Gang Chen, M.D.
First Affiliated Hospital of Wenzhou Medical University
PRINCIPAL INVESTIGATOR

Study Design

Study Type: observational
Observational Model: CASE CONTROL
Time Perspective: PROSPECTIVE
Target Duration: 10 Years
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Clinical Professor, Principal Investigator

Study Record Dates

First Submitted

April 9, 2022

First Posted

April 21, 2022

Study Start

May 1, 2020

Actual (reported)

Primary Completion

August 11, 2021

Actual (reported)

Relationship Between Liver Cancer and Sarcopenia

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

First Submitted

First Posted

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (2)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Biospecimen

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Study Officials

Study Design

Study Record Dates

You may not qualify if:

Intervention Hierarchy (Ancestors)

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

First Submitted

First Posted

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (2)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Biospecimen

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Study Officials

Study Design

Study Record Dates

You may not qualify if:

Intervention Hierarchy (Ancestors)

Data Sharing

Source record

Locations